OtherFiled on BSE ·
Emcure Pharmaceuticals receives ₹57.74 crore penalty orders from Income-tax Dept.
Emcure Pharma · Pharmaceuticals & Biotechnology
What the filing says
- Penalty imposed for Financial Years 2014-15 to 2020-21 (Assessment Years 2015-16 to 2021-22)
- Aggregate penalty amount is ₹57,73,96,732
- Company is evaluating legal remedies including an appeal before the Appellate Authority
Original filing
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Waaree Energies
Electrical Equipment
Revenue growth 40%+Margin up 2%+
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Other other filings this fortnight
- SEBI imposes penalty on SMC Global Securities Ltd. for regulatory violations
- OtherIdeaforge TechideaForge Technology Limited receives ₹54.59 crore GST tax and penalty demand order
- OtherBlue Dart ExpresBlue Dart Express subsidiary receives GST show cause notice for tax demand
- OtherVarun BeveragesVarun Beverages updates on arbitration over South African acquisition deal
- OtherKNR Construct.KNR Constructions Limited receives penalty orders from Income Tax authorities for AY 2017-21
- OtherShriram Finance LtdShriram Finance Limited fined ₹67.90 crore penalty for AY 2009-10 tax violation
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.